Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
Lonza Group Ltd. is seeking a Compliance Auditor to drive global cGMP audits across biologics, sterile products, APIs and devices. The role emphasizes collaboration with international manufacturing sites and regulators while maintaining inspection readiness.
The ideal candidate will bring 10+ years in cGMP QA/auditing and hold an MSc in a related field, with extensive MHRA/HPRA inspector experience and ability to travel internationally.
Compliance Auditor x3 Location: Manchester - Remote
This role involves significant international travel (50–60%) across global manufacturing sites and operational facilities.
As a Corporate Compliance Auditor, you will play a pivotal role in safeguarding Lonza’s license to operate by driving compliance excellence and mitigating quality risks worldwide.
Acting as a trusted technical advisor, you will design, plan, and execute high-impact corporate cGMP audits across a diverse global footprint—spanning biologics, cell and gene therapies, sterile drug products, APIs, medical devices, and hardware/software operations.
In this high-visibility global role, you will partner directly with manufacturing sites to elevate standards, navigate complex regulatory landscapes, and ensure continuous inspection readiness.
At Lonza, our people are our greatest strength. With 30+ sites across five continents, our globally connected teams work together every day to manufacture the medicines of tomorrow.
Our core values of Collaboration, Accountability, Excellence, Passion and Integrity reflect who we are and how we work together. Everyone’s ideas, big or small, have the potential to improve millions of lives, and that’s the kind of work we want you to be part of.
Innovation thrives when people from all backgrounds bring their unique perspectives to the table. At Lonza, we value diversity and are committed to creating an inclusive environment for all employees.
If you’re ready to help turn our customers’ breakthrough ideas into viable therapies, we look forward to welcoming you on board.